ANNUAL REPORT 2009-2010 - University of Toronto Department of ...

ANNUAL REPORT 2009-2010
Poster Presentations
P-A1 INVESTIGATING BIOMARKERS FOR THE EARLY DETECTION OF
OVARIAN CANCER
Joshua Durbin [G](1,4), Guo Xiong Xu (1), Despina Voulgaraki (1), Thomas Kislinger (4),
Theodore Brown (2,3), Michelle Letarte (1,3,4)(1)Molecular Structure and Function, Hospital
for Sick Children, Toronto, ON, Canada, (2)Department of Physiology, University of Toronto,
Toronto, ON, Canada, (3)Department of Obstetrics and Gynecology, University of Toronto,
Toronto, ON, Canada, (4)Department of Medical Biophysics, University of Toronto, Toronto,
ON, Canada
P-A2 THE OVARIAN MICROENVIRONMENT OVERCOMES THE ANTI-TUMOUR
EFFECT OF SPARC ON OVARIAN CANCER PROGRESSION
James Greenaway[PD](1), Anne Koehler(2), Chris McCulloch(2), Jim Petrik(3), Maurice
Ringuette(4) and Theodore Brown(1),
(1)Department of Obstetrics & Gynecology, University of Toronto and Samuel Lunenfeld
Research Institute, Toronto, (2)Matrix Dynamics, Faculty of Dentistry, University of Toronto,
(3)Dept of Biomedical Sciences, University of Guelph, (4)Dept of Cell and Systems Biology,
University of Toronto
P-A3 FEMALE ONCOLOGY PATIENTS AND FERTILITY PRESERVATION: ONE
FERTILITY CENTRE’S EXPERIENCE
Kaajal Abrol[R](1), Madeline Tonelli(2), Samantha Yee(2), Catherine Dwyer(2), Kimberly
Liu(1,2).
(1)Department of Obstetrics and Gynecology, University of Toronto.
(2)Reproductive Biology Unit, Mount Sinai Hospital, Toronto.
P-A4 RISK OF MALIGNANCY INDEX: HOW FEASIBLE IS IT TO CALCULATE THE
SCORE
Hannah Chiu [M] (1), Jason Dodge (2)
(1) Faculty of Medicine, University of Toronto (2) Department of Gynecologic-oncology,
Princess Margaret Hospital, University Health Network
P-A5 PREVALENCE OF BRCA1 AND BRCA2 GERM LINE MUTATIONS AMONG
WOMEN WITH CARCINOMA OF THE FALLOPIAN TUBE
Danielle Vicus [F](1,3), Amy Finch(1), Ilana Cass(2), Barry Rosen(3), Joan Murphy(3), Isabel
Fan(4), Robert Royer(1), John McLaughlin(4,5), Beth Karlan(2), Steven A. Narod(1)
(1)Women’s College Research Institute, (2)Cedars Sinai Medical Centre, Los Angeles,
California, USA (3)Department of Gynecology Oncology, University Health Network, University
of Toronto(4)Samuel Lunenfeld Research Institute,
(5)Cancer Care Ontario, Toronto.
P-A6 VEPH1 IS A NOVEL REGULATOR OF TGF-ß SIGNALING IN OVARIAN
CANCER CELLS.
Premalatha Shathasivam [G](1,2,3), A. Kollara(1,3), J. Wrana(1,4), T. J. Brown(1,2,3).(1)
Samuel Lunenfeld Research Institute, Mount Sinai Hospital; Departments of (2)Physiology,
(3)Obstetrics and Gynecology, and (4)Medical Genetics and Microbiology, University of
Toronto.
104